España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Solventum
SOLV
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$74.88
-0.26
-0.35%
At close: -
$74.88
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Solventum (SOLV) Forecast
News
Earnings
Solventum (SOLV) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Solventum (NYSE:SOLV) Stock
Solventum Stock (NYSE: SOLV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 08, 2025
8 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Solventum shares are trading higher after Nel...
Benzinga Newsdesk
Live On CNBC, Trian Says Solventum Trades At ...
Benzinga Newsdesk
Wednesday, December 04, 2024
5 Analysts Have This To Say About Solventum
Benzinga Insights
Mizuho Initiates Coverage On Solventum with N...
Benzinga Newsdesk
Thursday, November 14, 2024
Nelson Peltz's Trian Fund Management Reshaped Portfolio Ahead Of Presidential Election
Henry Khederian
Trian Fund Management 13F Shows Added Stake I...
Benzinga Newsdesk
Solventum Launches 3D Printed Clarity Precisi...
Benzinga Newsdesk
Monday, November 11, 2024
Critical Insights From Solventum Analyst Ratings: What You Need To Know
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Solv...
Benzinga Newsdesk
Friday, November 08, 2024
Piper Sandler Maintains Neutral on Solventum,...
Benzinga Newsdesk
Thursday, November 07, 2024
Solventum Raises 2024 Adjusted EPS Outlook Fr...
Benzinga Newsdesk
Solventum Raises Full-year 2024 Organic Sales...
Benzinga Newsdesk
Solventum Q3 2024 Adj EPS $1.64 Beats $1.39 E...
Benzinga Newsdesk
Thursday, October 24, 2024
Solventum shares are trading higher on a repo...
Benzinga Newsdesk
Solventum Taps Bankers to Explore Sale of Pur...
Benzinga Newsdesk
Tuesday, October 08, 2024
Stifel Initiates Coverage On Solventum with B...
Benzinga Newsdesk
Monday, October 07, 2024
Piper Sandler Initiates Coverage On Solventum...
Benzinga Newsdesk
Thursday, September 26, 2024
Decoding 4 Analyst Evaluations For Solventum
Benzinga Insights
Wolfe Research Initiates Coverage On Solventu...
Benzinga Newsdesk
Thursday, September 12, 2024
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy
Zacks
Tuesday, September 10, 2024
Solventum Has Launched V.A.C. Peel And Place ...
Benzinga Newsdesk
Thursday, September 05, 2024
Deep Dive Into Solventum Stock: Analyst Perspectives (5 Ratings)
Benzinga Insights
BTIG Initiates Coverage On Solventum with Neu...
Benzinga Newsdesk
Friday, August 23, 2024
Live On CNBC, Jenny Harrington Announces Sold...
Benzinga Newsdesk
Thursday, August 15, 2024
Disney Still Makes Up A Chunk Of Peltz's Trian Fund Despite $4B Exit, Records Show
Michael Juliano
Monday, August 12, 2024
Goldman Sachs Maintains Sell on Solventum, Ra...
Benzinga Newsdesk
Friday, August 09, 2024
Solventum Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Benzinga Insights
Wells Fargo Maintains Equal-Weight on Solvent...
Benzinga Newsdesk
Solventum shares are trading higher after the...
Benzinga Newsdesk
Thursday, August 08, 2024
Solventum Raises 2024 Adj. EPS Guidance From ...
Benzinga Newsdesk
Solventum Q2 2024 Adj. EPS $1.56 Beats $1.50 ...
Benzinga Newsdesk
Tuesday, July 23, 2024
Market-Moving News for July 23rd
Benzinga Newsdesk
Solventum shares are trading higher following...
Bill Haddad
Monday, July 22, 2024
Solventum shares are trading higher following...
Benzinga Newsdesk
Peltz's Trian Reportedly Builds Stake In 3M S...
Benzinga Newsdesk
Monday, July 15, 2024
Solventum Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Solv...
Benzinga Newsdesk
Wednesday, July 10, 2024
Goldman Sachs Maintains Sell on Solventum, Lo...
Benzinga Newsdesk
Friday, July 05, 2024
Watching MediWound; Traders Circulate Solvent...
Benzinga Newsdesk
Tuesday, June 25, 2024
Key Takeaways From Solventum Analyst Ratings
Benzinga Insights
B of A Securities Maintains Neutral on Solven...
Benzinga Newsdesk
Monday, June 24, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Solventum Introduces Denials Prevention Solut...
Benzinga Newsdesk
Monday, June 17, 2024
Tommy Tuberville Sells Several Large Stock Positions, Makes New Buys: Here's What The US Senator Is Betting On Now
Chris Katje
Thursday, May 30, 2024
Goldman Sachs Initiates Coverage On Solventum...
Benzinga Newsdesk
Friday, May 10, 2024
B of A Securities Initiates Coverage On Solve...
Benzinga Newsdesk
Thursday, May 09, 2024
Solventum Q1 2024 Adj EPS $2.08 Beats $1.75 E...
Benzinga Newsdesk
Tuesday, April 30, 2024
What's Going On With Post-It Maker 3M Shares Today?
Akanksha Bakshi
Wednesday, April 10, 2024
Morgan Stanley Initiates Coverage On Solventu...
Benzinga Newsdesk
Show More
